Engineered T-cells for Childhood Cancers
August 29, 2013
This type of immunotherapy is at the vanguard of clinical cancer research and has demonstrated early dramatic results including complete responses in some adults and children with leukemia. Researchers are now attempting to duplicate this success with pediatric solid tumors.
We are excited to have Dr. Chrystal Louis, Assistant Professor of Pediatrics - Hematology/Oncology at Baylor College of Medicine and Texas Children's Hospital present an overview of the progress and evolution of this arena in immunotherapy for children. Dr. Louis and her colleagues at Baylor/Texas Children's are among the leading investigators in the world in novel immunotherapy for childhood cancers.